SCHEDULE: ARK Investment Management Discloses Strata Medical Stake

ARK Investment Management LLC and Catherine D. Wood have filed an amendment to their Schedule 13G, reporting beneficial ownership of 3.16% of Strata Critical Medical, Inc. common stock as of June 30, 2026.

Summary

• ARK Investment Management LLC and Catherine D. Wood have jointly filed an amendment (Amendment No. 7) to their Schedule 13G filing.
• This filing pertains to their beneficial ownership of the Common Stock of Strata Critical Medical, Inc.
• As of June 30, 2026, the aggregate amount beneficially owned by ARK Investment Management LLC and Catherine D. Wood is 2,730,855 shares.
• This represents 3.16% of the class of securities.
• ARK Investment Management LLC holds sole voting and dispositive power over these shares.
• Catherine D. Wood holds shared voting and dispositive power over these shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating continued strategic interest from a prominent investment firm, but without new financial performance data.

Positives

• ARK Investment Management LLC and Catherine D. Wood maintain a significant stake, indicating confidence in Strata Critical Medical, Inc.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it is a disclosure of beneficial ownership.

Management Comments

• ARK Investment Management LLC and Catherine D. Wood agree to file Amendment No. 7 on Schedule 13G relating to their ownership of the Common Stock of the Issuer, and agree that said Amendment No. 7 shall be filed on behalf of each of them.
• Kellen Carter, Chief Compliance Officer for ARK Investment Management LLC, certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.
• Catherine D. Wood, Chief Executive Officer and Chief Investment Officer, certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by ARK Investment Management, known for its focus on disruptive innovation, indicates a strategic investment in Strata Critical Medical, Inc. This aligns with ARK's typical investment thesis in companies poised for significant growth within their respective sectors.

Stakeholder Impact

• Shareholders may view ARK's continued investment as a positive signal, potentially influencing market perception and share price.
• The filing confirms ARK's role as a significant institutional investor, which can impact the company's strategic direction and governance.

Next Steps

• ARK Investment Management LLC and Catherine D. Wood will continue to hold and potentially manage their beneficial ownership of Strata Critical Medical, Inc. common stock.
• Future amendments to the Schedule 13G will be filed if ownership levels change significantly.

Key Dates

Keywords

Strata Critical Medical, ARK Investment Management, Catherine D. Wood, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Management